For example, Asian women are generally shorter, have a lower body mass index (BMI) but are more likely to be centrally obese, and have a milder hyperandrogenic phenotype. In addition, clinical selection and planning of AED therapy may vary between Asian and Western WWE. To date, there is a paucity of PCOS studies in Asian WWE and data regarding PCOS in Chinese WWE, to the best of our knowledge, is still limited. Thus, we designed this study to investigate the incidence and risk factors of PCOS in Chinese WWE.
Methods

Subjects
WWE at reproductive ages were recruited at the Department of Neurology, First Affiliated Hospital, Sun Yat-Sen University (Guangzhou, China). Exclusion criteria include progressive brain disease, existing diseases in other organs, pregnancy or lactation, use of psychiatric medicines, oral contraceptives or other hormonal preparations, and those who had undergone hysterectomy. One hundred and thirty-nine patients matched with the study design and were enrolled. Among them, 102 patients had completed the study process. The study was approved by the local Ethics Committee and informed consent obtained from all patients. During the study period, patients were kept in contact via telephone or email and at particular time points, interviewed face-to-face at the hospital for clinical evaluation, pathological laboratory investigations and ultrasound examination.
Clinical examination and medical records
Detailed medical history was obtained from each patient, including the age of start of seizure, frequency of seizures, menstrual history, current medication, and other existing diseases. Epilepsy was diagnosed and the type classified by the standard of the International League Against Epilepsy (1981), in which magnetic resonance imaging (MRI) was regularly performed on patients except those who were clearly diagnosed with other non-MRI assessments. Weight, height, and BMI were recorded. Overweight was defined as having a BMI of !24. Hirsutism was determined and scored using the Ferryman and Gallwey system, 10 with scores !9 as defined hirsutism. Menstrual disorders were recorded as amenorrhea (absence of a menstrual period), oligomenorrhea (cycle length longer than 35 days during the last 6 months), and irregular menstrual cycles (cycle length varying more than 4 days, at least once during the last 6 months).
B-mode ultrasonography
A transvaginal or transabdominal (in the case with an intact hymen) B-mode ultrasonography was performed by using a 3.5 MHz transducer to detect ovarian volume, the number and size of ovarian follicles, and stromal echogenicity during the period of the first 14 days of menstrual cycle. Polycystic ovary was defined as each ovary existing with 12 or more follicles with size >2 mm in diameter and/or volume of ovary >10 mL.
Assessment of circulating hormones
Fasting blood samples were drawn through a forearm vein at early follicular phase (days 2-5) of the menstrual cycle, centrifuged immediately to separate the serum, and stored in a À20 8C freezer. Blood (serum) concentrations of testosterone (T), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin (PRL), dehydroepiandrosterone sulfate (DHEAS), estrodial (E2) and progestogen (P) were measured using chemiluminescent microparticle immunoassay kits (Abbott Laboratories, USA). In measurements the reference range of T was 0.09-1.3 mg/L, LH 1-18 IU/L, FSH 4-13 IU/L, PRL 1.39-29.93 mg/L, DHEAS 0.2-13.9 mmol/L, E2 390-1890 pg/L, and P 2.7-26.1 ng/L, with intraand inter-assay coefficients with variation less than 8%.
Serum concentration of T > 10.0 mg/L was defined as hyperandrogenism. In our study, positive clinical symptoms/signs were usually present when serum levels of T was >10.0 mg/L. Patients with a single laboratory report of T > 10.0 mg/L but no clinical symptoms/signs were not included as cases of hyperandrogenism, in which the hormonal increment was transient and returned back to normal without particular treatment during the follow-up period.
Definition of PCOS
PCOS was diagnosed based on a coexistence of 2 or more of these components: polycystic ovaries, hyperandrogenism, and a/ oligomenorrhoea. Although polycystic ovaries are the pathological basis of PCOS, ultrasonography of a sufficient standard is still not widely available for the diagnosis of the polycystic ovary. 11 In the case of the absence of the defined polycystic ovary, PCOS would be defined by an accepted standard for clinical diagnosis of PCOS, i.e. existence of an ovulatory dysfunction (functional a/oligomenorrhoea) with clinical evidence of hyperandrogenism and exclusion of secondary causes or related disorders such as hyperprolactinaemia, thyroid disorders and non classical adrenal hyperplasia. 
Statistical analysis
Data was analyzed by a computer with SPSS 11.0 software (SPSS, Chicago, IL, U.S.A.) and p scores <0.05 were considered as significant. Categorical variables were compared by a Chi-square test and Fisher's exact test. For continuous variables, an unpaired ttest was used for comparing two groups and ANOVA with Bonferroni correction (two-tailed) for more than two groups. Risk factors of the reproductive disorders were analyzed with Binary logistic regression. 
Results
Clinical characteristics (Table 1)
The mean age of these 102 WWE was 22 years, ranging from 12-to 45-year-old, and 88.2% patients were under 30-year-old. 
Incidence of PCOS and its isolated components
There were 54.9% (56/102) patients with one or more of PCOS's components, including polycystic ovaries (29/102, 28.4%), a/ oligomenorrhoea (20/102, 19.6%), and hyperandrogenism (7/ 102, 6.9%), and among them 13 cases (12.7%) were diagnosed as PCOS. Several risk factors for these reproductive disorders were further analyzed ( Table 2 ). The mean age at the start of seizures was 13.8 AE 6.5 years in these patients with reproductive dysfunction, with most cases under 16 years old. This is significantly younger than that of cases without the endocrine disorders (16.9 AE 8.6 years, p < 0.05). Although the length of time during which these patients suffered seizures was relatively long (over 5 years in average), it is not statistically different to that in cases without endocrine disorders. There were also no statistical differences in the type or frequency of epilepsy among patients with or without these reproductive endocrine disorders. The occurrence of PCOS and its isolated components, however, was associated with AEDs, particularly VPA therapy (see below).
VPA therapy and PCOS
Among the 72 Chinese WWE who used AEDs (Table 3) , patients on VPA therapy, either alone or together with another AED, had significantly higher incidence of PCOS (11/32, 34.4%), a/oligomenorrhea (13/32, 40.6%), polycystic ovaries (16/32, 50%), and hyperandrogenism (5/32, 15.6%), in comparison to those without therapy. A further analysis (Table 4) , however, could not ascertain whether or not the increased incidence of PCOS was associated to the possible change of BMI during VPA therapy, or to other issues including the dosage, duration, and the age at the start of use of VPA therapy.
Circulating hormone levels
Circulating levels of sex hormones are presented in Table 5 . Serum level of testosterone was significantly higher in patients Table 2 Incidence and risk factor analysis of PCOS and its isolated components in Chinese WWE (n = 102).
AEDs
Polycystic ovaries A/oligomenorrhoea Hyperandrogenism PCOS who accepted VPA than those without VPA therapy, although the average level of the hormone did not reach to that of the defined hyperandrogenism. Serum LH level and LH/FSH ratio were also significantly higher in VPA-treated WWE (p < 0.05, compared to those without the AED therapy). There were no statistical changes in the levels of these hormones in patients who accepted non-VPA AEDs compared to those without AED therapy.
Discussion
Little information is available with regards to PCOS in Chinese WWE. The present study, for the first time, investigated the incidence and risk factors of PCOS in Chinese WWE at reproductive ages. The study found that 54.9% (56/102) cases have at least one of the major isolated components of PCOS, such as polycystic ovaries, hyperandrogenism, and a/oligomenorrhea. The incidence rate of PCOS in these Chinese WWE was 12.7% (13/ 102), around 2 to 3-folds of that in healthy women. 1, 2 This rate is similar to that reported in Indian WWE (about 11.8%), 12 but lower than that in some reports in Western WWE (up to 26%). 3 Incidence of PCOS in Chinese WWE was associated with seizure start age and VPA therapy: patients who started suffering seizures at ages 16 years or accepted VPA therapy were at relatively higher risk of PCOS. The causes and mechanisms underlying the occurrence of PCOS in WWE are still not fully clear. Electrical discharges, both interictally and during generalized and partial seizures, may alter the secretion of pituitary and gonadal hormones, 3, 13, 14 which may result in reproductive dysfunction. Studies in western WWE 1, 3, 6, 7 have shown that reproductive endocrine and sexual dysfunction are more common in patients with partial epilepsy than patients with generalized epilepsy, particular that of temporal lobe origin. In our study, however, no significant difference in PCOS incidence between partial and generalized epilepsy have been found in Chinese WWE, which is similar to a recent report in Indian WWE. 12 In fact, the relationship between seizure type and PCOS incidence has not been found consistently in some western WWE. For example, studies in Austrian and Italian WWE showed that reproductive endocrine disorders occurred in similar frequency irrespective of the type as well as frequency of seizures. 15, 16 These studies, as well as the fact that high incidence of PCOS can also occur in WWE with well-controlled seizures, implicate that the seizure type and frequency are not prominent elements for PCOS. Our study showed that the age at the start of seizures, but not the type, duration and frequency of the disease, is related to PCOS, with younger WWE ( 16 years old) having relatively higher incidence of this disorder. It is well known that AEDs, particularly VPA, may change serum concentrations of reproductive hormones in patients with epilepsy, thus contributing to the development of reproductive dysfunction including PCOS. [17] [18] [19] [20] Therefore in this study we paid particular attention to the incidence and risk factors of PCOS in the Chinese WWE undergoing AEDs therapy. In agreement with the studies by Isojä rvi et al., 8, [16] [17] [18] [19] [20] [21] our study found an increased frequency of PCOS and its major isolated components in the Chinese WWE undertaking VPA therapy, with the incident rate of polycystic ovaries at 50.0%, a/oligomenorrhea 40.6%, hyperandrogenism 15.6%, and PCOS 34.4%. However, we could not clarify the relationship of the dose and duration of VPA therapy to these reproductive endocrine disorders, possibly due to the relatively small sample size in this study. A previous prospective study in Indian WWE found an increased incidence of menstrual disturbance and polycystic ovaries in the first two years of VPAtherapy in women. 22 Similarly, in this study on Chinese WWE about 1/3 (4 of 13) of cases of PCOS were diagnosed during the first 2 years of VPA therapy and longer VPA treatment (over 2 years) did not significantly increase the incidence (Table 4 ). To date the minimum time of VPA therapy use which would cause reproductive dysfunction is still unknown. Although in our study the incidence of PCOS in the WWE with non-VPA AEDs was relatively lower than that in the VPA-treated patients (Table 3) , we could still not exclude the possible side effects of these AEDs on reproductive function. This is because the sample size for each non-VPA AED was too small to complete such assessments. Although increased PCOS in WWE using VPA therapy has been reported in many studies, the underlying mechanisms and pathogenesis are still not fully understood. As the use of VPA is often associated with increased weight and hyperinsulinemia, it is suggested that obesity and associated hyperinsulinemia contribute to the development of polycystic ovaries and hyperandrogenism in WWE who use VPA therapy. 9, 16, 20 In this present study with 32
Chinese WWE with VPA therapy (Table 4) , more than 1/3 (4 in 11) of patients with PCOS have been found to be overweight (IBM ! 24) whereas less than 1/5 (3 in 21) of those without PCOS were. Although this difference did not reach statistical significance due to a small sample size in this study, the result still supports that obesity is associated with the occurrence of PCOS in WWE who use VPA therapy. VPA therapy may affect sex hormone production. Studies in vitro demonstrated that VPA directly stimulated ovarian production of androgens, leading to increased circulating levels of these sex hormones and thus reproductive disorders including PCOS. 23 Our study showed that circulating levels of testosterone were significantly elevated in the Chinese WWE with VPA therapy (Table 5 ). In this study blood LH levels and LH/FSH ratio in the patients with VPA therapy were also found to be higher than those without the AED therapy, but we could not confirm that the increased LH was an initial issue caused by VPA treatment or a secondary issue (feedback phenomenon) following PCOS.
Although high serum LH levels may also increase ovarian synthesis of androgens, previous studies found that VPA was not associated with elevated serum LH levels. 16, 17 Therefore, the role of high LH in VPA-induced PCOS remains uncertain.
Limitations of the study
The major limitation of our study was a small sample size, particularly small numbers of WWE in antiepileptic subgroups.
Conclusion
The study demonstrates that PCOS occurs in 12.7% of Chinese WWE at reproductive ages, by more than 2 times of that in a healthy population. The incidence of PCOS as well as its isolated components is associated with the age at the start of seizures, with higher frequency of these reproductive endocrine disorders occurring in those who had younger ages of seizure onset ( 16 years old). VPA therapy is another important risk factor associated with PCOS in Chinese WWE. At this time, the underlying mechanisms remain unclear. Larger prospective studies which would provide the information about relationships between the dose and duration of VPA therapy as well as the use of other AEDs to the onset of PCOS symptoms in Chinese WWE are required.
